Fiorella Manfredi

Immune Checkpoint Inhibitor Rechallenge in Renal Cell Carcinoma: Current Evidence and Future Directions

L. Galli, A. Antonuzzo, E. Sammarco, 2023, Cancers.

Concomitant Administration of VEGFR Tyrosine Kinase and Proton Pump Inhibitors May Impair Clinical Outcome of Patients With Metastatic Renal Cancer.

V. Conteduca, S. Fogli, U. de Giorgi, 2024, Clinical genitourinary cancer.